Tamsulosin HCL 0.4 MG capsule 1000S
Ended Awarded
- Contract number
- SPE2DB25FTWN2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,423
Award facts
- Contract value 100% obligated
- $10,422.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,422.50 to DMS Pharmaceutical Group Inc. for the supply of 1,000 units of Tamsulosin HCL 0.4 mg capsules, with an ultimate completion date of September 25, 2025. This firm fixed-price delivery order was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its location in Conshohocken, Pennsylvania.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which carries a ceiling value of $499,999,999 and remains valid through November 2026. The IDC enables the DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support military healthcare facilities worldwide. Tamsulosin HCL, a generic alpha-blocker medication used to treat benign prostatic hyperplasia, represents one of the routine pharmaceutical supply items distributed through this contract vehicle to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FTWN2?
SPE2DB25FTWN2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FTWN2 worth?
The government has obligated $10,423 on SPE2DB25FTWN2.
Is contract SPE2DB25FTWN2 an order under another contract?
Yes. SPE2DB25FTWN2 is a delivery order under SPE2DB20D6037, an indefinite delivery contract.
Was contract SPE2DB25FTWN2 competed?
The extent of competition for SPE2DB25FTWN2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award